SCHEMBL5286843

SCHEMBL5286843

CCN[CH]S(=O)(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSIP1 O75475 1/20 0.48
▸ TLR9 Q9NR96 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 5/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ MCOLN3 Q8TDD5 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ HTR6 P50406 1/20 0.39
▸ HSD11B1 P28845 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.38
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ MMP1 P03956 1/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ MMP9 P14780 1/20 0.38
▸ MMP8 P22894 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5294940 0.85 PSIP1 (0.45) PSIP1TLR9KDM4EALDH1A1CYP1A2
SCHEMBL4589049 0.81 CA1 (0.46) ALDH1A1CYP2C19NPSR1SMN1; SMN2CA1
SCHEMBL5966694 0.78 ADH1B (0.53) TLR9ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL4587825 0.77 TLR9 (0.52) PSIP1TLR9ALDH1A1CYP1A2CYP2C9
SCHEMBL5966882 0.73 CA2 (0.44) KDM4EALDH1A1CA1CA2MMP1
SCHEMBL1264868 0.72 PSIP1 (0.54) PSIP1TLR9KDM4EALDH1A1CYP1A2
SCHEMBL5284134 0.72 TLR9 (0.47) PSIP1TLR9KDM4EALDH1A1CYP1A2
SCHEMBL5281571 0.71 TLR9 (0.50) TLR9ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL4394025 0.69 PSIP1 (0.50) PSIP1TLR9ALDH1A1CYP1A2CYP2C9
SCHEMBL6465522 0.69 TLR9 (0.59) PSIP1TLR9ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 — — US claimed
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 — — WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 PSIP1 2369/4885TLR9 1893/4885KDM4E 4305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback